Get the Stockscreener App
0.9478
1.70%
0.0158
After Hours:
.92
-0.0278
-2.93%
Elutia Inc stock is traded at $0.9478, with a volume of 28,923.
It is up +1.70% in the last 24 hours and down -5.10% over the past month.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
See More
Previous Close:
$0.932
Open:
$0.9158
24h Volume:
28,923
Relative Volume:
0.27
Market Cap:
$41.90M
Revenue:
$15.97M
Net Income/Loss:
$-24.40M
P/E Ratio:
-1.2496
EPS:
-0.7585
Net Cash Flow:
$-45.82M
1W Performance:
-0.91%
1M Performance:
-5.10%
6M Performance:
+50.92%
1Y Performance:
-54.65%
1-Day Range:
$0.89
$0.9502
1-Week Range:
$0.89
$0.9939
52-Week Range:
$0.50
$2.64
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.9478 | 43.31M | 15.97M | -24.40M | -45.82M | -0.7585 |
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Elutia Inc.(NasdaqCM: ELUT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Elutia Inc.(NasdaqCM: ELUT) added to Russell 3000E Growth Benchmark - marketscreener.com
Elutia Inc Class A Actuals & Estimates (NASDAQ:ELUT) - TradingView
Enterprise value to EBITDA forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to sales forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
ELUT Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to book forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Form 4 Elutia Inc For: 22 June By Investing.com - Investing.com South Africa
Elutia (ELUT) CEO reports RSU vesting and tax withholding, boosting share holdings - Stock Titan
Elutia Inc (ELUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Elutia Inc (ELUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elutia Inc (ELUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elutia Inc (ELUT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elutia Inc (ELUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elutia Inc (ELUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Elutia Inc (ELUT) Institutional Confidence - TradingKey
Elutia Inc (ELUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Elutia Inc (ELUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
ELUT: Drug-eluting biologic for breast reconstruction targets high infection rates in a $1.5B market - TradingView
Elutia Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesBanking Earnings Report - newsline.com
Elutia Inc. (NASDAQ: ELUT) Files 8-K with Updated Company Information and Key SEC Details – June 2026 - Minichart
Elutia shareholders approve board proposals at annual meeting - Investing.com
Elutia shareholders approve board proposals at annual meeting By Investing.com - Investing.com India
Elutia Shareholders Approve Amended Incentive Plan and Governance - TipRanks
Elutia (ELUT) investors approve equity plan amendment and annual say-on-pay - Stock Titan
Elutia Inc. (ELUT) Q1 2026 Earnings: EPS Misses Estimates as Company Navigates Early-Stage PipelineRevenue Warning Signal - newsline.com
Elutia (ELUT) grants director Kevin Rakin 159,590 stock options - Stock Titan
Elutia (NASDAQ: ELUT) director awarded 106K stock options as compensation - Stock Titan
Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike - Stock Titan
Elutia (NASDAQ: ELUT) director Brigid Makes receives 106,393-share stock option grant - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Ticks UpNext Quarter Guidance - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Edges Higher Despite SurpriseShare Dilution Risk - newsline.com
ELUTIA (ELUT) CSO reports RSU vesting and tax withholding share disposition - Stock Titan
Elutia (ELUT) CFO reports RSU vesting and tax withholding event - Stock Titan
Elutia (ELUT) CEO RSUs vest; shares withheld to cover taxes - Stock Titan
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th - BioSpace
Breast reconstruction infections: Elutia to outline biomatrix tech in Vegas - Stock Titan
Elutia Inc. (ELUT) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesMargin Guidance - newsline.com
Elutia Inc. (ELUT) Edges Higher: Approaching Resistance Amid Low-Volume RallyRectangle Pattern - newsline.com
Elutia Inc. (ELUT) Edges Higher: Stock Gains 3.49% as Price Approaches Key ResistanceEqual Weight ETF - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Moves HigherEarnings Surprise Report - dars.gov.et
Elutia Inc. (ELUT) Slips Nearly 5% as Stock Tests Key Support LevelsDescending Triangle - newsline.com
Elutia Inc. (ELUT) Shows Signs of Weakening Momentum Near Support LevelsOrder Block - newsline.com
Despite Elutia's Pullback, Insiders Still Gained US$75k - simplywall.st
Elutia (ELUT) director gifts shares and updates trust, HighCape stakes - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Nearly 7%Profit Announcement - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates on Higher Operating CostsDownward Estimate Revision - newsline.com
Elutia Inc. (ELUT) Holds Near Key Support After Marginal DeclineChannel Projection - newsline.com
Elutia Stock Flat Ahead of Open as $1.5 Billion Decision Waits - Bez Kabli
Elutia Inc. (ELUT) Slips 3.33% as Stock Tests Key Support LevelsStop Run - The Legal Advocate
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elutia Inc Stock (ELUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| NEELS GUIDO J | Director |
Jan 30 '26 |
Buy |
1.04 |
20,000 |
20,800 |
118,750 |
| NEELS GUIDO J | Director |
Jan 29 '26 |
Buy |
1.06 |
15,000 |
15,900 |
98,750 |
| NEELS GUIDO J | Director |
Jan 28 '26 |
Buy |
1.06 |
15,000 |
15,900 |
83,750 |
2.62%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):